Legato Capital Management’s Gilead Sciences GILD Stock Holding History

Legato Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$387K	Sell	3,064 -1,152	-27%	-$152K	0.03%	539
2026 Q1	$588K	Sell	4,216 -2,800	-40%	-$392K	0.05%	504
2025 Q4	$861K	Buy	+7,016	New	+$853K	0.07%	391
2021 Q2	–	Sell	-26,500	Closed	-$1.71M	–	369
2021 Q1	$1.71M	Hold	26,500	–	–	0.32%	95
2020 Q4	$1.54M	Hold	26,500	–	–	0.29%	101
2020 Q3	$1.68M	Buy	+26,500	New	+$1.84M	0.37%	85

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Legato Capital Management's GILD Position: Q2 2026 in Review

Legato Capital Management reduced its Gilead Sciences (GILD) stake by 27% in Q2 2026, selling an estimated $152K and leaving 3,064 shares worth $387K. The position accounts for 0.03% of the portfolio, ranked #539.

Legato Capital Management first reported a position in GILD in Q3 2020 and has held it in 6 quarters since. The position peaked at $1.71M in Q1 2021. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Legato Capital Management held 3,064 shares of Gilead Sciences worth $387K as of Q2 2026.
Legato Capital Management sold 1,152 Gilead Sciences shares in Q2 2026, an estimated $152K.
Gilead Sciences made up 0.03% of Legato Capital Management's portfolio in Q2 2026, its #539 holding.
Legato Capital Management first reported a position in Gilead Sciences in Q3 2020 and has held it in 6 quarters since.
Legato Capital Management's Gilead Sciences position peaked at $1.71M in Q1 2021.
2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Legato Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.